Belvedere Trading »

Fulcrum Therapeutics shares owned by Belvedere Trading

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Belvedere Trading from 13F filings

Historical chart of Belvedere Trading investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by Belvedere Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by Belvedere Trading

Quarter filed Position value Share count Share price at filing
2024-09-30 $60k 17k 3.57
2024-06-30 $95k 15k 6.20
2022-03-31 $201k 16k 12.73

More positions owned by Belvedere Trading

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Meta Platforms Cl A (META)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Spdr Gold Tr Gold Shs (GLD)
Apple Call Option (AAPL)
Amazon (AMZN)
Advanced Micro Devices Call Option (AMD)
Microstrategy Cl A New (MSTR)
Super Micro Computer (SMCI)
Ishares Silver Tr Ishares Call Option (SLV)
Vaneck Etf Trust Semiconductr Etf (SMH)
Graniteshares Etf Tr 2x Long Nvda Dai (NVDL)

View all positions for Belvedere Trading

Top funds holding Fulcrum Therapeutics

RA Capital Management
BlackRock
BlackRock
Nantahala Capital Management
Caption Management
Vanguard Group
Suvretta Capital Management
Trv Gp Iv
Citadel Advisors
Perceptive Advisors
Logos Global Management
MPM Oncology Impact Management
Leucadia National Corporation
Dimensional Fund Advisors
Geode Capital Management

View all funds holding Fulcrum Therapeutics